Kumiyo Ashida

411 citations
15 papers · 314 indexed · h-index 10

Kumiyo Ashida

15 papers receiving 307 citations

Peers

Kumiyo Ashida
Comparison fields: 5 of 61
  • Surgery 116
  • Oncology 94
  • Molecular Biology 81
  • Pathology and Forensic Medicine 55
  • Physiology 53
Replace Francesco Volta with:
Francesco Volta Italy
Yangmeng Wang United States
Christophe Rey France
Fukashi Matsuzaki Japan
Xuemei Ge United States
Yeo Kyoung Oh South Korea
Sangwon Byun United States
Shinya Ishimaru Japan
E Liong Hong Kong
Pengchao Du China
Kumiyo Ashida relative to Francesco Volta Italy Francesco Volta's profile →
Citations per field
00.5×1.5×2.0×
Francesco Volta · 1×
Citations per year

Countries citing papers authored by Kumiyo Ashida

Since Specialization
Citations

This map shows the geographic impact of Kumiyo Ashida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumiyo Ashida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumiyo Ashida more than expected).

Fields of papers citing papers by Kumiyo Ashida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumiyo Ashida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumiyo Ashida. The network helps show where Kumiyo Ashida may publish in the future.

Co-authorship network of co-authors of Kumiyo Ashida

This figure shows the co-authorship network connecting the top 25 collaborators of Kumiyo Ashida. A scholar is included among the top collaborators of Kumiyo Ashida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumiyo Ashida. Kumiyo Ashida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 41
2 54
3 29
4
Clinical significance of serum P53 antibody in patients with gastric cancer.
18
5 41
6 34
7 5
8 25
9 18
10 3
11 11
12 2
13 1
14
[Natural killer (NK) activity and NK subsets in patients with inflammatory bowel disease].
2
15 30

About Kumiyo Ashida

Kumiyo Ashida is a scholar working on Biochemistry, Biochemistry and Physiology, having authored 15 papers that have together received 314 indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Biochemistry (26 citations), Oncology (94 citations) and Pathology and Forensic Medicine (55 citations). Kumiyo Ashida has collaborated with scholars based in Japan. Frequent co-authors include Yoshinori Kamisaki, Yosuke Kishimoto, Kentaro Nakamoto, Kouichirou Wada, Tadao Itoh, Maki Fujiwara, K. Nakazawa, Hironaka Kawasaki, Takahisa Ohta and K. Takashima. Their work appears in journals such as Life Sciences, American Journal of Physiology-Gastrointestinal and Liver Physiology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026